Related Experiment Videos

Cimetidine induced pancytopenia. Effect on human CFU-MIX colony formation

W Uyttenbroeck1, M Korthout, R De Bock

  • 1Laboratory of Experimental Haematology, University of Antwerp, Belgium.

Blut
|June 1, 1990
PubMed

Insights

Cimetidine can cause pancytopenia by inhibiting human multipotent progenitor cells (CFU-MIX). This drug blocks H2 histamine receptors, preventing cell cycle progression and DNA synthesis, impacting blood cell production.

Area of Science:

  • Hematology
  • Pharmacology
  • Cell Biology

Background:

  • Pancytopenia is a potential side effect of cimetidine.
  • The exact mechanism of cimetidine-induced bone marrow toxicity requires elucidation.

Observation:

  • Cimetidine demonstrated a dose-dependent inhibition of normal human CFU-GM colony formation.
  • CFU-MIX colony formation showed significantly greater toxicity compared to CFU-GM, even at therapeutic cimetidine concentrations.
  • Inhibition of CFU-MIX was observed irrespective of accessory cells, suggesting a direct effect.

Findings:

  • Cimetidine directly inhibits human CFU-MIX colony formation.
  • A significant decrease in CFU-MIX colony size was noted at therapeutic cimetidine levels.
  • The study suggests the presence of H2 histamine receptors on human CFU-MIX cells.

Implications:

  • Cimetidine's toxicity may stem from blocking H2 histamine receptors on multipotent progenitor cells.
  • This receptor blockade could impede the DNA synthesis phase of the cell cycle.
  • Understanding this mechanism could inform strategies to mitigate cimetidine-related hematological adverse effects.

Related Concept Videos